{"id":"https://genegraph.clinicalgenome.org/r/7a12e476-567b-40bf-9ea6-45ac5e39c627v3.0","type":"EvidenceStrengthAssertion","dc:description":"*CD164* was first reported in relation to autosomal dominant nonsyndromic hearing loss (AD NSHL) in 2015 (Nyegaard et al., PMID: 26197441). One pathogenic nonsense variant has been reported in 4 probands in 3 publications (PMIDs: 26197441, 35254497, 36454368). This variant was detected in families from different genetic ancestry groups which suggests that the Arg192 residue is a mutational hotspot, rather than a founder variant. This variant was found to segregate in 24 additional family members in two families (PMID: 26197441, 35254497). This gene disease relationship is also supported by expression and protein interaction studies (PMID: 26197441). In summary there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease association. This gene-disease pair was originally evaluated by the ClinGen Hearing Loss GCEP on 3/20/2018 as per SOP v6. It was reevaluated on 6/25/2024 using SOP v10. As a result of this reevaluation, new case level evidence has been reviewed or added, but the classification did not change (PMIDs: 35254497, 36454368, 36597107).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/7a12e476-567b-40bf-9ea6-45ac5e39c627","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e9524ca4-7d17-4691-b650-0d457531c7fd","calculatedEvidenceStrength":"Moderate","changes":[{"id":"cg:newEvidence"},{"id":"cg:summaryChange"},{"id":"cg:classificationChange"},{"id":"cg:sopChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e9524ca4-7d17-4691-b650-0d457531c7fd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2024-06-25T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e9524ca4-7d17-4691-b650-0d457531c7fd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2024-08-07T15:47:37.652Z","role":"Publisher"}],"curationReasons":["RecurationCommunityRequest"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9524ca4-7d17-4691-b650-0d457531c7fd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9524ca4-7d17-4691-b650-0d457531c7fd_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/616897c7-b4c0-440f-8c90-b2639c83bf79_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35254497","rdfs:label":"Family 2 ","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/616897c7-b4c0-440f-8c90-b2639c83bf79","type":"Family","rdfs:label":"Family 2 ","member":{"id":"https://genegraph.clinicalgenome.org/r/d246cd66-322b-4a11-88e6-79d0a95b96d9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35254497","rdfs:label":"Proband Family 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":25,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e54c0592-abaf-4493-959c-337a6cab714a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006016.6(CD164):c.574C>T (p.Arg192Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10581228"}},"detectionMethod":"Targeted sequencing of custom HL gene panel (237 genes) ","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000408","obo:HP_0008619"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f20070df-2a78-40e1-9f9e-bd22c862945f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35254497","allele":{"id":"https://genegraph.clinicalgenome.org/r/e54c0592-abaf-4493-959c-337a6cab714a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000408","obo:HP_0008619"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d246cd66-322b-4a11-88e6-79d0a95b96d9"}},{"id":"https://genegraph.clinicalgenome.org/r/6d63f378-e751-4546-97aa-00de51045b47_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36454368","rdfs:label":"Moresco Family 7","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/6d63f378-e751-4546-97aa-00de51045b47","type":"Family","rdfs:label":"Moresco Family 7","member":{"id":"https://genegraph.clinicalgenome.org/r/83fe168c-1735-4024-9bf3-b02721284462","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36454368","rdfs:label":"Proband III-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/e54c0592-abaf-4493-959c-337a6cab714a"},"detectionMethod":"Trio WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"slight non- specific brain dysmorphisms","phenotypes":["obo:HP_0008936","obo:HP_0000486","obo:HP_0008619","obo:HP_0002360","obo:HP_0001115","obo:HP_0000639","obo:HP_0001270"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/65fa0fa2-4393-4122-a5b7-9f33c7efa250_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36454368","allele":{"id":"https://genegraph.clinicalgenome.org/r/e54c0592-abaf-4493-959c-337a6cab714a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"slight non- specific brain dysmorphisms","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001115","obo:HP_0008619","obo:HP_0000639","obo:HP_0001270","obo:HP_0000486","obo:HP_0002360","obo:HP_0008936"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/83fe168c-1735-4024-9bf3-b02721284462"}},{"id":"https://genegraph.clinicalgenome.org/r/da6cb2f8-eaee-494f-9b9e-41cdd00b8f83_proband_segregation","type":"FamilyCosegregation","dc:description":"Approved at 3 points for segregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26197441","rdfs:label":"Nyegaard Family","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/da6cb2f8-eaee-494f-9b9e-41cdd00b8f83","type":"Family","rdfs:label":"Nyegaard Family","member":{"id":"https://genegraph.clinicalgenome.org/r/3f38d2b3-2a5d-4c92-bf1b-b20b36f4eec0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26197441","rdfs:label":"Family Proband 5","allele":{"id":"https://genegraph.clinicalgenome.org/r/e54c0592-abaf-4493-959c-337a6cab714a"},"detectionMethod":"Locus specific capture and next-generation sequencing\nGenome wide linkage analysis performed","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"moderate to severe, age of onset varied from newborn, age 3-6, to early 20s. Audiograms either flat at all frequencies or basin shape w/ most severe HL at mid-freq. In some HL was stable, in others was progressive","previousTesting":true,"previousTestingDescription":"testing for WFS1, GRHL2, EYA4, ACTG1, GJB2, MYO6 exon 25, SLC26A4 was negative","secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3e79ddac-fad8-45b9-bab7-f266e819ff08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26197441","allele":{"id":"https://genegraph.clinicalgenome.org/r/e54c0592-abaf-4493-959c-337a6cab714a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"moderate to severe, age of onset varied from newborn, age 3-6, to early 20s. Audiograms either flat at all frequencies or basin shape w/ most severe HL at mid-freq. In some HL was stable, in others was progressive","phenotypePositiveAllelePositive":12,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3f38d2b3-2a5d-4c92-bf1b-b20b36f4eec0"},"publishedLodScore":5.1,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/60b1ac7d-198c-4fa1-940d-a6f1419009bf_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35254497","rdfs:label":"Family 1","estimatedLodScore":3.01,"family":{"id":"https://genegraph.clinicalgenome.org/r/60b1ac7d-198c-4fa1-940d-a6f1419009bf","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/073bacf5-5dd4-4158-a125-a59bfce5661d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35254497","rdfs:label":"Proband III.3, Family 1 ","allele":{"id":"https://genegraph.clinicalgenome.org/r/e54c0592-abaf-4493-959c-337a6cab714a"},"detectionMethod":"Targeted sequencing of custom HL gene panel (237 genes) ","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000399","obo:HP_0000408"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7d9feecb-8df8-4e3d-ac5c-f923989d567f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35254497","allele":{"id":"https://genegraph.clinicalgenome.org/r/e54c0592-abaf-4493-959c-337a6cab714a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":14,"proband":{"id":"https://genegraph.clinicalgenome.org/r/073bacf5-5dd4-4158-a125-a59bfce5661d"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/f20070df-2a78-40e1-9f9e-bd22c862945f","type":"EvidenceLine","dc:description":"This variant seems to be a mutational hotspot so it is scored at 0.5 points ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f20070df-2a78-40e1-9f9e-bd22c862945f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/65fa0fa2-4393-4122-a5b7-9f33c7efa250","type":"EvidenceLine","dc:description":"This variant escapes NMD but is scored at 0.5 points as it is a mutational hotspot","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65fa0fa2-4393-4122-a5b7-9f33c7efa250_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7d9feecb-8df8-4e3d-ac5c-f923989d567f","type":"EvidenceLine","dc:description":"This variant seems to be a mutational hotspot so it was scored at 0.5 points","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d9feecb-8df8-4e3d-ac5c-f923989d567f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3e79ddac-fad8-45b9-bab7-f266e819ff08","type":"EvidenceLine","dc:description":"Truncation did not impair protein stability or glycosylation state, and did not affect ability to form heterodimers with wild-type CD164. Variant evades NMD in peripheral blood cells of proband.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e79ddac-fad8-45b9-bab7-f266e819ff08_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3e79ddac-fad8-45b9-bab7-f266e819ff08_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis of variant demonstrated truncation causes abnormal trafficking- WT localized to intracellular vesicles while mutant localized to plasma membrane. Truncation did not impair protein stability or glycosylation state, and did not affect ability to form heterodimers with wild-type CD164. Variant evades NMD in peripheral blood cells of proband.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.5},{"id":"https://genegraph.clinicalgenome.org/r/e9524ca4-7d17-4691-b650-0d457531c7fd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9524ca4-7d17-4691-b650-0d457531c7fd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/296ef3e4-73c5-4028-ae22-cd16816dd9f9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6a86b8b-0d03-4880-90d2-06f5fe9346f6","type":"Finding","dc:description":"Cd164 was expressed in mouse cochlea at P5. The protein localized to cochlear neurons, IHCs, OHCs, Kollikerâ€™s organ, lateral cochlear wall, and stria vascularis","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26197441","rdfs:label":"Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a5533bb3-731e-4ed2-8900-e02eb684067a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b61a3d9-a38e-4366-b108-3db4abb584b4","type":"Finding","dc:description":"R192X mutation was shown to not affect disulfide homodimerization of CD164 protein. Also did not have an effect on WT CD164 internalization when mutant and WT were cotransfected and differentially tagged ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26197441","rdfs:label":"Protein interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Moderate","sequence":8773,"specifiedBy":"GeneValidityCriteria10","strengthScore":6.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ioisZGYytgU","type":"GeneValidityProposition","disease":"obo:MONDO_0019587","gene":"hgnc:1632","modeOfInheritance":"obo:HP_0000006"},"version":"3.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e9524ca4-7d17-4691-b650-0d457531c7fd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}